◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

RPG Life Sciences Limited (RPGLIFE) Financial History

Name: RPG Life Sciences Limited (RPGLIFE) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

RPG Life Sciences Limited (RPGLIFE) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 1,366 employees. Its market capitalization is roughly ₹46 billion. In the fiscal year ended 2026-03-31, RPGLIFE reported ₹7.0B in revenue and ₹1.2B in net income.

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.

Interactive charts & full statements →

RPGLIFE Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹7.0B	₹6.5B	₹5.8B	₹5.1B
Gross Profit	₹4.4B	₹4.2B	₹3.8B	₹3.3B
Operating Income (EBIT)	₹1.3B	₹1.4B	₹1.1B	₹889M
Net Income	₹1.2B	₹1.8B	₹877M	₹676M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RPGLIFE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	₹2.0B	₹1.8B	₹1.8B	₹1.7B	₹1.4B
Gross Profit	₹1.3B	₹1.2B	₹1.2B	₹1.1B	₹944M
Operating Income (EBIT)	₹374M	₹271M	₹344M	₹303M	₹201M
Net Income	₹308M	₹299M	₹221M	₹263M	₹1.2B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RPGLIFE Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹397M)	(₹265M)	(₹198M)	(₹159M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RPGLIFE Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹7.9B	₹6.6B	₹5.1B	₹4.2B	—
Total Liabilities	₹1.9B	₹1.3B	₹1.4B	₹1.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RPGLIFE viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

GUJTHEM · Gujarat Themis Biosyn Limited — ₹56 billion
NOVARTIND · Novartis India Limited — ₹51 billion
ORCHPHARMA · Orchid Pharma Limited — ₹50 billion
4554 · Fuji Pharma Co., Ltd. — JPY 49 billion
2196 · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. — HK$46 billion
GUFICBIO · Gufic Biosciences Limited — ₹44 billion
AARTIDRUGS · Aarti Drugs Limited — ₹39 billion
UNICHEMLAB · Unichem Laboratories Limited — ₹38 billion

← RPGL All “R” companies RPH →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.